[Skip to Navigation]
March 1985


Author Affiliations

Charleston, SC

Arch Otolaryngol. 1985;111(3):208. doi:10.1001/archotol.1985.00800050102018

To the Editor.—A recent article by Clutter et al1 presented an left orbital roof osteoblastoma removed by curettage. Though no patient follow-up was given, the authors asserted that regression of such tumors occurs in a high percentage of cases after incomplete removal and "may represent a change in the local immune status or merely inactivity of residue tumor." The latter (quote) is conjecture. Very few reports have sufficient follow-up to document cure, given that tumor persistence has manifested up to nine years following surgery. The recent head and neck literature indicates that complete excision of benign osteoblastoma is the therapy of choice.2-4 As stated by Batsakis,5 "incomplete excision will yield recurrence and a non-radical en bloc excision is advised." Of the 14% of osteoblastomas that occur in the head and neck region, curettage has been primarily applied to alveolar arch tumors that can be curetted with

Add or change institution